The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Generic filters
Generic filters






The University of Western Australia

Professor Nigel Laing is a world-renowned scientist whose work has turned Australia into an international reference centre for neuromuscular diseases. He has identified more than twenty human disease genes and has the rare honour of having a disease named after him. He established the premier diagnostic laboratory for neurogenetic disorders in Australasia, receiving patient samples from around the world.

Nigel actively engages with patient support groups, raising public understanding of medical science.

As a leader, he has been elected five times to the World Muscle Society Board, is a Member of Senate of UWA and is an awarded mentor.

Co-Director, Centre for Cancer Biology
SA Pathology and The University of South Australia

Professor Sharad Kumar’s ground-breaking work in biomedical sciences has been recognised through prestigious fellowships, national and international awards, and election to the Fellowship of the Australian Academy of Science. He has made seminal discoveries that have significantly contributed to the understanding of human diseases such as cancer, inflammation and hypertension. His publications have received extensive citations. With Angel Lopez he established the Centre for Cancer Biology, a leading research centre in South Australia. He has built collaborative teams, bringing major infrastructure funding and contributed to research community extensively through leadership, mentoring and peer review.

Senior Director, Research Therapeutic Area Lead
CSL Limited
Council Member

Professor Bronwyn Kingwell’s fundamental and clinical research in arterial biomechanics has driven new approaches for the management of arterial diseases. She has pioneered the transition of detailed cellular and molecular studies of high-density lipoprotein (HDL) in laboratory models, in particular with regard to glucose metabolism, to a human context. This work has opened major new avenues in HDL therapeutics for treatment of diabetes. Her contributions have also influenced national and international physical activity guidelines. Professor Kingwell has been a leader in defining Australian science policy and is an active mentor.

Chief Executive
Melbourne Health

Although for several decades Professor Kilpatrick contributed to improving health outcomes through clinical practice and research, her key contribution and of relevance to Fellowship of the Academy has been her leadership roles in which she has ensured a strong and sustainable integration between medical research and health care delivery. This has been achieved through articulating a clear vision, relationship building and creating opportunities for integration. As CEO Royal Children’s Hospital, she has taken a lead role in establishing the Melbourne Children’s the partnership between RCH, University of Melbourne and Murdoch Children’s Research Institute, to ensure research is embedded in healthcare delivery.

Deputy Chief Medical Officer, Department of Health
Australian National University

Professor Michael Kidd AM is an academic general practitioner with a distinguished national and international reputation in health and medical science as a researcher, educator and medical leader. He is a highly regarded international leader in general practice and primary care, has a strong record of advocacy and public service, and has made many contributions to health policy and practice through academic positions, government appointments and professional and community service. His contributions to medical and health science include research in general practice, ehealth, health policy, education, safety and quality, and the primary care management of HIV and sexually transmissible infections.

Coordinator, QIMR Centre for Immunotherapy and Vaccine Development; Senior Scientist, Tumour Immunology Laboratory
QIMR Berghofer Medical Research Institute

Professor Khanna is an internationally recognized Translational Immunologist who has made major contributions in the development of cellular immunotherapies for the treatment of virus-associated cancers and infectious complications. He has also developed novel immune-based diagnostic tools which have been successfully commercialised and implemented in clinical settings. He is the founding Director of the QIMR Centre for Immunotherapy and Vaccine Development which has been recognized for excellence in research by national and international organizations. He has been invited by various National and International organizations to provide expert advice on the development of clinical guidelines and public awareness of advances in medical research.

Deputy Director
NHMRC Clinical Trials Centre, The University of Sydney

Professor Anthony Keech has made sustained important contributions to clinical and basic research to improve Australian and international health through his career, and continues to do so. He is an internationally-renowned cardiologist and clinical triallist with formal expertise in epidemiology, who co-directs the NHMRC Clinical Trials Centre in Sydney, with over 160 personnel. He has helped to lead global trials of most of the major established treatments for the care of acute myocardial infarction and has influenced policy locally and internationally, especially in the areas of MI care, lipid management to reduce cardiovascular risk and the treatment of diabetes.

Head, Heart Failure Division, Baker Heart and Diabetes Institute; Director, Department of Cardiology, Alfred Hospital
Baker Heart and Diabetes Institute

Professor Kaye is an internationally recognised clinician-scientist working who has made a major contribution to the understanding and treatment of heart failure. Prof Kaye is an NHMRC Senior Principal Research Fellow at Baker IDI and an active senior Cardiologist in the Heart Failure- Transplant Unit at the Alfred Hospital, Melbourne. Professor Kaye holds numerous research grants including an NHMRC Program Grant, NHMRC Centre of Research Excellence Grant and an NHMRC Development Grant, with cumulative competitive grant support in excess of $44M. Prof Kaye’s translational research has also created a substantial portfolio of intellectual property that has led to the invention of novel medical devices and pharmacological therapies, including 2 spin-out companies that have raised >$100M.

Executive Director
Sydney Health Partners

Professor Garry Jennings is Director of Baker IDI. He is Past President of the Asia Pacific Society of Hypertension, the Association of Australian Medical Research Institutes (AAMRI), and of the High Blood Pressure Research Council of Australia and Head of a WHO Collaborating Centre. He is Associate Editor of the American Heart Association journal Hypertension. A cardiologist at The Alfred Hospital and Adjunct Professor at Monash University, he performed landmark studies of the benefits of exercise, sympathetic pathophysiology of cardiovascular disease, cardiac hypertrophy, indigenous cardiovascular health and clinical trials. He has published over 400 papers in peer-reviewed journals cited over 18,500 times.

Head and Professor of Medicine, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences
Monash University, Alfred Health

Professor Stephen Jane is Head of Central Clinical School, Professor of Medicine, Monash University, Director of Research, Alfred Health and Acting Head of Clinical Haematology and The Australian Centre for Blood Diseases. He was previously a Principal Research Fellow of the NHMRC, Professor of Medicine, University of Melbourne and Director of the Bone Marrow Research Laboratories, Royal Melbourne Hospital. His research interests centre on transcriptional regulation in blood and skin, and he currently holds six NH&MRC grants and international competitive funding. He has published over 100 papers including articles in Science, Nature Medicine, Cancer Cell and Developmental Cell.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2022
Newly elected Fellows of 2022 are inducted at the Annual Meeting.

Late September 2022-November 2022
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2022
Nominations allocated to Selection Committees.

January – April 2023
Referees’ reports sought.

Early May 2023
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2023
Council meets to finalise recommendations.

Late July 2023
Full Fellowship invited to comment on recommended new fellows.

August 2023
Election results are shared with proposers and candidates (under embargo).

October 2023
Newly elected Fellows of 2023 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.